BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26402225)

  • 1. Placental growth factor promotes metastases of ovarian cancer through MiR-543-regulated MMP7.
    Song N; Liu H; Ma X; Zhang S
    Cell Physiol Biochem; 2015; 37(3):1104-12. PubMed ID: 26402225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placental Growth Factor Promotes Ovarian Cancer Cell Invasion via ZEB2.
    Song N; Liu H; Ma X; Zhang S
    Cell Physiol Biochem; 2016; 38(1):351-8. PubMed ID: 26824454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells.
    Dong P; Xiong Y; Watari H; Hanley SJ; Konno Y; Ihira K; Yamada T; Kudo M; Yue J; Sakuragi N
    J Exp Clin Cancer Res; 2016 Sep; 35(1):132. PubMed ID: 27596137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-133b inhibits proliferation and invasion of ovarian cancer cells through Akt and Erk1/2 inactivation by targeting epidermal growth factor receptor.
    Liu X; Li G
    Int J Clin Exp Pathol; 2015; 8(9):10605-14. PubMed ID: 26617770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-143 inhibits colorectal cancer cell proliferation by targeting MMP7.
    Yu B; Liu X; Chang H
    Minerva Med; 2017 Feb; 108(1):13-19. PubMed ID: 27827523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNACASC9 promotes proliferation, metastasis, and cell cycle inovarian carcinoma cells through cyclinG1/TP53/MMP7 signaling.
    Sun M; Chen Y; Liu X; Cui Y
    Bioengineered; 2021 Dec; 12(1):8006-8019. PubMed ID: 34595994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-497 promotes metastasis of colorectal cancer cells through Nrdp1 inhibition.
    Jiang Y; Meng Q; Qi J; Shen H; Sun S
    Tumour Biol; 2015 Sep; 36(10):7641-7. PubMed ID: 25926384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-340 Induces Apoptosis and Inhibits Metastasis of Ovarian Cancer Cells by Inactivation of NF-x03BA;B1.
    Li P; Sun Y; Liu Q
    Cell Physiol Biochem; 2016; 38(5):1915-27. PubMed ID: 27160777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-574-3p exerts as a tumor suppressor in ovarian cancer through inhibiting MMP3 expression.
    Zheng J; Zhou Y; Li XJ; Hu JM
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6839-6848. PubMed ID: 31486483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR‑508‑3p suppresses the development of ovarian carcinoma by targeting CCNA2 and MMP7.
    Guo F; Zhang K; Li M; Cui L; Liu G; Yan Y; Tian W; Teng F; Zhang Y; Gao C; Gao J; Wang Y; Xue F
    Int J Oncol; 2020 Jul; 57(1):264-276. PubMed ID: 32377701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin-mediated expression of placenta growth factor is regulated via activation of hypoxia-inducible factor-1α and post-transcriptionally by miR-214 in sickle cell disease.
    Gonsalves CS; Li C; Mpollo MS; Pullarkat V; Malik P; Tahara SM; Kalra VK
    Biochem J; 2015 Jun; 468(3):409-23. PubMed ID: 25876995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCNB1, Negatively Regulated by miR-559, Promotes the Proliferation, Migration, and Invasion of Ovarian Carcinoma Cells.
    Yang X; Zhou S; Yang C; Cao C; He M; Zi S
    Mol Biotechnol; 2022 Sep; 64(9):958-969. PubMed ID: 35262876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
    Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
    Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placental growth factor promotes metastases of non-small cell lung cancer through MMP9.
    Zhang W; Zhang T; Lou Y; Yan B; Cui S; Jiang L; Han B
    Cell Physiol Biochem; 2015; 37(3):1210-8. PubMed ID: 26418253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-200a inhibits CD133/1+ ovarian cancer stem cells migration and invasion by targeting E-cadherin repressor ZEB2.
    Wu Q; Guo R; Lin M; Zhou B; Wang Y
    Gynecol Oncol; 2011 Jul; 122(1):149-54. PubMed ID: 21529905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-532 and microRNA-3064 inhibit cell proliferation and invasion by acting as direct regulators of human telomerase reverse transcriptase in ovarian cancer.
    Bai L; Wang H; Wang AH; Zhang LY; Bai J
    PLoS One; 2017; 12(3):e0173912. PubMed ID: 28291810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNA-34a decreases ovarian cancer cell proliferation and chemoresistance by targeting HDAC1.
    Lv T; Song K; Zhang L; Li W; Chen Y; Diao Y; Yao Q; Liu P
    Biochem Cell Biol; 2018 Oct; 96(5):663-671. PubMed ID: 29561664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA PVT1 promotes cell proliferation and invasion through regulating miR-133a in ovarian cancer.
    Yang Q; Yu Y; Sun Z; Pan Y
    Biomed Pharmacother; 2018 Oct; 106():61-67. PubMed ID: 29957467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-508 suppresses epithelial-mesenchymal transition, migration, and invasion of ovarian cancer cells through the MAPK1/ERK signaling pathway.
    Hong L; Wang Y; Chen W; Yang S
    J Cell Biochem; 2018 Sep; 119(9):7431-7440. PubMed ID: 29781537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-507 inhibits the migration and invasion of human breastcancer cells through Flt-1 suppression.
    Jia L; Liu W; Cao B; Li H; Yin C
    Oncotarget; 2016 Jun; 7(24):36743-36754. PubMed ID: 27167339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.